Table 1. Serovar genotype and antimicrobial resistance profile of V. parahaemolyticus isolated from 2001–2012.
| Serovar* | tdh + trh − | tdh − trh + | tdh + trh + | tdh − trh − | Strain category** | Resistant profile* | |
| Pandemic | Non-pandemic | ||||||
| O1:KUT (20) | 16 | 2 | 1 | 1 | 16 | 4 | AM (2); AM,S (18) |
| O1:K25 (33) | 33 | 33 | AM (5); AM,S (25); AM,C,S (1); AM,NA,S (1); # (1) | ||||
| O1:K30 (2) | 1 | 1 | 1 | 1 | AM,S (2) | ||
| O1:K36 (11) | 11 | 11 | AM,S (11) | ||||
| O1:K38 (3) | 2 | 1 | 1 | 2 | AM (1), AM,S (2) | ||
| O1:K56 (3) | 3 | 1 | 2 | AM,S (3) | |||
| O2:K3 (8) | 8 | 8 | AM (1), AM,S (7) | ||||
| O2:K4 (1) | 1 | 1 | AM,S | ||||
| O2:K9 (1) | 1 | 1 | AM,S | ||||
| O3:KUT (12) | 11 | 1 | 12 | S(1), AM,S(11) | |||
| O3:K5 (1) | 1 | 1 | AM,S | ||||
| O3:K6 (35) | 35 | 32 | 3 | AM(6); AM,S(25); AM,C,S(1);AM,NA,S(2); # (1) | |||
| O3:K30 (1) | 1 | 1 | AM,S | ||||
| O4:KUT (1) | 1 | 1 | AM,S | ||||
| O4:K4 (1) | 1 | 1 | AM | ||||
| O4:K8 (12) | 12 | 12 | AM(4); AM,S(7); AM,NA,S(1) | ||||
| O4:K9 (3) | 3 | 3 | AM,S(3) | ||||
| O4:K11 (4) | 4 | 4 | AM,S(4) | ||||
| O4:K12 (1) | 1 | 1 | AM,S | ||||
| O4:K13 (1) | 1 | 1 | AM | ||||
| O4:K25 (1) | 1 | 1 | AM,S | ||||
| O4:K37 (4) | 4 | 4 | AM,S(4) | ||||
| O4:K55 (2) | 2 | 1 | 1 | AM,S(2) | |||
| O4:K68 (3) | 3 | 3 | AM,S(2); AM,NA,S(1) | ||||
| O5:KUT (2) | 2 | 2 | AM,S(2) | ||||
| O5:K15 (1) | 1 | 1 | AM,S | ||||
| O5:K17 (1) | 1 | 1 | # | ||||
| O8:KUT (3) | 3 | 3 | AM (1); AM,S(2) | ||||
| O8:K21 (1) | 1 | 1 | AM,S | ||||
| O10:K60 (4) | 4 | 4 | AM(2); AM,S(2) | ||||
| O10:K61 (1) | 1 | 1 | AM,S | ||||
| OUT:KUT (1) | 1 | 1 | AM,C,NA,S,SXT,T | ||||
| Total | 169 (94.9%) | 3 (1.7%) | 2 (1.1%) | 4 (2.2%) | 121 (68%) | 57 (32%) | |
* Numbers in parentheses denote number of strains;
**categorized by GS-PCR;
#
, susceptible to all antimicrobial agents.
Abbreviations: AM, ampicillin; C, cholarmphenicol; Na, nalidixic acid; S, streptomycin; SXT, trimethoprim/sulfamethoxazole.